Detalhe da pesquisa
1.
Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms.
Nature
; 588(7836): 157-163, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33239784
2.
PLCG1 is required for AML1-ETO leukemia stem cell self-renewal.
Blood
; 139(7): 1080-1097, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34695195
3.
Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG).
Mol Cell Proteomics
; 15(4): 1435-52, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26785728
4.
Therapeutic effect of androgen therapy in a mouse model of aplastic anemia produced by short telomeres.
Haematologica
; 100(10): 1267-74, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26206796
5.
Histone demethylase KDM4C is a functional dependency in JAK2-mutated neoplasms.
Leukemia
; 36(7): 1843-1849, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35654819
6.
YBX1 mediates translation of oncogenic transcripts to control cell competition in AML.
Leukemia
; 36(2): 426-437, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34465866
7.
A20/TNFAIP3 Discriminates Tumor Necrosis Factor (TNF)-Induced NF-κB from JNK Pathway Activation in Hepatocytes.
Front Physiol
; 8: 610, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28878689